← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 31, 2022Last known activity
Dec 31, 2025
Timeline
2020s
- Jun 1, 2020
DualityBio Inc.— Founded
Drugs by trial phase (16 distinct, 15 trials)
Phase 3 (6 own, 0 via acquisition)
Recent trials (25)
- NCT07263594OfficialPhase 1/Phase 2Dec 31, 2025
- NCT07263594Lead sponsorPhase 1/Phase 2Dec 31, 2025
- NCT07141706OfficialPhase 1Sep 23, 2025
- NCT07141706Lead sponsorPhase 1Sep 23, 2025
- NCT06953089Lead sponsorPhase 2Jul 18, 2025
- NCT06892548CollaboratorPhase 1/Phase 2May 2, 2025
- NCT06827236CollaboratorPhase 1/Phase 2Apr 30, 2025
- NCT06340568CollaboratorPhase 3Nov 30, 2024
- NCT06625671OfficialPhase 1Oct 4, 2024
- NCT06625671Lead sponsorPhase 1Oct 4, 2024
- NCT06554795Lead sponsorPhase 1/Phase 2Sep 3, 2024
- NCT06554795OfficialPhase 1/Phase 2Sep 3, 2024
- NCT06018337Lead sponsorPhase 3Jan 31, 2024
- NCT06018337Study directorPhase 3Jan 31, 2024
- NCT06265428Lead sponsorPhase 3Jan 29, 2024
Details
- Founded
- beijing, CN Jun 1, 2020
- Last known activity
- Dec 31, 2025